New Hampshire Medicaid and semaglutide
Wegovy for weight loss: no. Still covered for other conditions such as heart event risk or a liver condition (MASH), with prior authorization. Ozempic for weight loss: no; for type 2 diabetes New Hampshire Medicaid must cover it. Read from New Hampshire Department of Health and Human Services, Division of Medicaid Services documents Nov 6, 2026.
In 2025 New Hampshire Medicaid paid for 21,492 semaglutide prescriptions (Wegovy, Ozempic, Rybelsus), 62% of its GLP-1 prescriptions and 39th of the 50 states and DC. It reimbursed $24.7 million before rebates, $1,149 a prescription against $1,104 nationally.
| Brand | Prescriptions | Medicaid paid | Per Rx |
|---|---|---|---|
| Wegovy | 12,961 | $16.4 million | $1,262 |
| Ozempic | 8,301 | $8.1 million | $974 |
| Rybelsus | 230 | $242,251 | $1,053 |
New Hampshire plans and prescribing rules
State of New Hampshire Health Benefit Plan. New Hampshire's Department of Administrative Services told the Governor and Council in August 2025 that the State Health Benefit Plan does not cover GLP-1 medications for weight loss.
Semaglutide in the states around New Hampshire
| State | Sell semaglutide, ship there | Cheapest | Medicaid Rx, 2025 | Medicaid, Wegovy for weight loss |
|---|---|---|---|---|
| New Hampshire | 19 | $39/moWellmedr | 21,492 | Medicaid Wegovy: No |
| Maine | 19 | $39/moWellmedr | 12,403 | Medicaid Wegovy: No |
| Massachusetts | 18 | $39/moWellmedr | 53,347 | Medicaid Wegovy: No |
| Vermont | 19 | $39/moWellmedr | 8,393 | Medicaid Wegovy: No |



